The explosion in demand for ketamine-assisted psychotherapy (“KAP”) has garnered significant media attention over the past few years—and the federal government has taken notice. In a case that should sound the alarms of every ketamine provider and clinic, prosecutors in the Eastern District of Missouri have escalated enforcement against ketamine providers, issuing criminal charges that resulted in prison time, probation, and a surrendered DEA license. Read below to learn more about the case and what it means for the future of DEA oversight of KAP.
Background
On January 11, 2024, the U.S. Attorney’s Office indicted two St. Louis area doctors on 22 felony counts, alleging illegal ketamine administration and fraudulent billing related to ketamine therapy services provided at COPE Ketamine Clinic, a psychiatric clinic offering KAP and other ketamine-based treatments for depression, anxiety, and PTSD.
The indictment charged Dr. Asim Muhammad Ali and Dr. Mohd Azfar Malik with participating in conspiracies to illegally distribute controlled substances and maintain a drug involved premises, twelve counts of illegal distribution of controlled substances, and seven counts of making false statements related to health care matters. The indictment stemmed from allegations that the providers were administering intravenous ketamine infusions and esketamine nasal sprays without authorization.
The Allegations
The government’s allegations outline a pattern of conduct that should give any ketamine provider pause. Specifically, the government alleged that the clinic’s physicians administered ketamine IVs and nasal sprays without authorization, did not have a proper DEA license, billed claims to Medicare under another provider’s name and billing number, and failed to properly store ketamine and esketamine at their clinic. If convicted, the providers faced decades of prison time, millions of dollars in financial penalties, and debarment from future participation in federal health care programs.
This case makes one thing abundantly clear: prosecutors are willing and ready to pursue criminal charges relating to providers’ practices in administering, billing for, and providing ketamine services.
Guilty Pleas and Sentencing Outcomes
Both doctors ultimately admitted wrongdoing in connection with these charges in 2025. Dr. Ali pleaded guilty to conspiracy to illegally distribute controlled substances and to maintain a druginvolved premises, resulting in a sentence of 70 months in federal prison. Dr. Malik pleaded guilty to two counts of making false statements related to federal healthcare matters based on ketamine treatment claims he submitted to Medicare, Medicaid, and private insurers, resulting in a sentence of five years’ probation, tens of thousands of dollars in restitution and fines, and surrender of his DEA controlled substance registration.
Why This Matters to Ketamine Providers
While this case quickly gained national attention as a striking example of the federal government’s increased focus on ketamine enforcement, the case is merely an example of what ketamine providers can expect moving forward. This case makes one thing abundantly clear: prosecutors are willing and ready to pursue criminal charges relating to providers’ practices in administering, billing for, and providing ketamine services. Those charges can result in not only substantial fines, but significant professional (and even criminal) liability.
For clinics and providers offering intravenous ketamine infusions, esketamine nasal sprays like Spravato, or other therapies involving controlled substances and psychoactive medications, this case emphasizes that serious federal exposure is possible if authorities challenge how services are structured or delivered.
Takeaway: Awareness Alone Isn’t Enough
If your practice involves ketamine administration, infusion models, or federal program billing, the St. Louis indictments and outcomes should serve as a stark reminder: federal prosecutors are watching and ready to pursue charges that can result in prison time, financial penalties, and potential revocation of your medical licensure.
Are you a provider facing a DEA audit or allegations relating to your ketamine services? Providers who engage counsel before an investigation disrupts their operations are more likely to come out with their reputations intact. Don’t wait—contact us today to learn how we can help.
MORE ARTICLES BY CATEGORY
Understanding UPIC Audits: A Guide for Healthcare Providers, Pharmacies, and Medical Practices
UPIC audits are serious government probes into suspected Medicare and Medicaid billing errors that can quickly turn from a simple paperwork check into a business-ending disaster, leading to frozen payments, massive fines, or criminal charges. Because the stakes are so high, healthcare providers use specialized lawyers to fight unfair findings, protect their licenses, and stop the government from escalating the case.
Read More >>CMS Imposes Nationwide Moratorium on Hospice and Home Health Enrollments: A Major Escalation in the J.D. Vance Task Force Crackdown
The Centers for Medicare & Medicaid Services (CMS) has imposed a six-month nationwide moratorium on new hospice and home health provider enrollments. While intended to combat a multi-billion-dollar fraud problem, the move is expected to trigger intense audits for existing providers in states across the country.
Read More >>Texas Moves to Rein in Ketamine Therapy—And Other States are Likely Next
The regulatory environment surrounding ketamine therapy is entering a new phase of maturity and enforcement. Recently, the Texas Medical Board published proposed regulations governing ketamine therapy, one of the first comprehensive regulatory frameworks in the country.
Read More >>California Hospice Fraud Crackdown: What it Means for Providers & How to Protect Your Business
California’s hospice fraud crackdown is only the beginning of what CMS and Medi-Cal regulators have claimed will be many more cases brought against hospice facilities and home health agencies. Providers who do not timely respond to a suspension or revocation may waive important rights. Act now to protect your business and reputation from governmental overreach based on data mining and other unreliable sources.
Read More >>
